Yenzym Antibodies, LLC

Brisbane, CA

UEI
HAZVKKTNF217
CAGE
4N8F5
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
100 N Hill Dr STE 34, Brisbane, CA 94005, USA
Website
yenzym.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $10,875

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Yenzym Antibodies, LLC registered in SAM.gov?

Yes. Yenzym Antibodies, LLC's SAM.gov registration is active through February 24, 2027.

How much has Yenzym Antibodies, LLC received in federal contracts?

Federal contracts obligated $10,875 to Yenzym Antibodies, LLC in fiscal years 2023 through 2027.

What is Yenzym Antibodies, LLC's most recent federal award?

Yenzym Antibodies, LLC's most recent federal contract award is Yenzym antibodies, LLC:1347960 [23-006476] (75N98B23P00021), from National Eye Institute (NIH), on September 8, 2023.

On GovTribe

See Yenzym Antibodies, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors